Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

An arthritis drug helped a person with severe hair loss regrow their hair.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.